Q3T0E1
PR
Gene name |
EXOSC3 (RRP40) |
Protein name |
Exosome complex component RRP40 |
Names |
Exosome component 3, Ribosomal RNA-processing protein 40 |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:533245 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q3T0E1
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q3T0E1-F1 | Predicted | AlphaFoldDB |
54 variants for Q3T0E1
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs473331947 | 2 | A>V | No | EVA | |
| rs439679385 | 3 | E>D | No | EVA | |
| rs457293991 | 4 | A>E | No | EVA | |
| rs475102837 | 5 | A>P | No | EVA | |
| rs434935910 | 7 | V>G | No | EVA | |
| rs452685402 | 14 | G>C | No | EVA | |
| rs480391114 | 23 | V>G | No | EVA | |
| rs446637614 | 25 | D>E | No | EVA | |
| rs458073540 | 27 | V>G | No | EVA | |
| rs453355422 | 32 | E>D | No | EVA | |
| rs470997655 | 33 | E>D | No | EVA | |
| rs437480818 | 34 | L>V | No | EVA | |
| rs479467283 | 42 | G>R | No | EVA | |
| rs463649429 | 44 | G>V | No | EVA | |
| rs481460857 | 46 | G>V | No | EVA | |
| rs441276453 | 47 | G>C | No | EVA | |
| rs1115251275 | 48 | A>T | No | EVA | |
| rs435222951 | 54 | R>S | No | EVA | |
| rs436964341 | 56 | N>K | No | EVA | |
| rs1115143699 | 58 | A>T | No | EVA | |
| rs448359055 | 60 | R>L | No | EVA | |
| rs459585178 | 61 | S>P | No | EVA | |
| rs461470580 | 62 | R>L | No | EVA | |
| rs443841107 | 62 | R>W | No | EVA | |
| rs443117715 | 67 | C>S | No | EVA | |
| rs437020681 | 85 | R>P | No | EVA | |
| rs470708183 | 85 | R>W | No | EVA | |
| rs465887547 | 88 | H>L | No | EVA | |
| rs465887547 | 88 | H>P | No | EVA | |
| rs477206759 | 89 | K>Q | No | EVA | |
| rs450177559 | 90 | E>D | No | EVA | |
| rs379265970 | 92 | G>V | No | EVA | |
| rs461580053 | 93 | S>R | No | EVA | |
| rs452085594 | 101 | W>G | No | EVA | |
| rs476276898 | 102 | V>G | No | EVA | |
| rs438559202 | 126 | G>* | No | EVA | |
| rs474215214 | 149 | A>P | No | EVA | |
| rs475016274 | 184 | C>G | No | EVA | |
| rs435072951 | 184 | C>W | No | EVA | |
| rs470521035 | 186 | R>G | No | EVA | |
| rs450369655 | 189 | G>R | No | EVA | |
| rs481678006 | 195 | Q>K | No | EVA | |
| rs469099266 | 200 | F>L | No | EVA | |
| rs435232058 | 201 | K>E | No | EVA | |
| rs446625556 | 201 | K>N | No | EVA | |
| rs458012441 | 202 | V>L | No | EVA | |
| rs440777021 | 213 | P>A | No | EVA | |
| rs476423092 | 215 | C>R | No | EVA | |
| rs436267815 | 221 | V>G | No | EVA | |
| rs465516796 | 229 | I>V | No | EVA | |
| rs438045716 | 236 | R>G | No | EVA | |
| rs449462347 | 236 | R>K | No | EVA | |
| rs460818665 | 242 | K>E | No | EVA | |
| rs477032347 | 269 | F>L | No | EVA |
No associated diseases with Q3T0E1
8 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasmic exosome (RNase complex) | A ribonuclease complex that has 3-prime to 5-prime processive hydrolytic exoribonuclease activity producing 5-prime-phosphomonoesters. Participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. Restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, esp if the 3-prime end is structured. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| euchromatin | A dispersed and relatively uncompacted form of chromatin that is in a transcription-competent conformation. |
| exosome (RNase complex) | A ribonuclease complex that has 3-prime to 5-prime exoribonuclease activity and possibly endoribonuclease activity, producing 5-prime-phosphomonoesters. Participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. Restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, esp if the 3-prime end is structured. |
| nuclear exosome (RNase complex) | A ribonuclease complex that has 3-prime to 5-prime processive and distributive hydrolytic exoribonuclease activity and endoribonuclease activity, producing 5-prime-phosphomonoesters. Participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. Restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, esp if the 3-prime end is structured. |
| nucleolus | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| organelle membrane | A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| RNA binding | Binding to an RNA molecule or a portion thereof. |
11 GO annotations of biological process
| Name | Definition |
|---|---|
| CUT catabolic process | The chemical reactions and pathways resulting in the breakdown of cryptic unstable transcripts (CUTs). |
| DNA deamination | The removal of an amino group from a nucleotide base in DNA. An example is the deamination of cytosine to produce uracil. |
| exonucleolytic catabolism of deadenylated mRNA | The chemical reactions and pathways resulting in the breakdown of the transcript body of a nuclear-transcribed mRNA that occurs when the ends are not protected by the 3'-poly(A) tail. |
| exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | Exonucleolytic digestion of a pre-rRNA molecule to generate the mature 3'-end of a 5.8S rRNA molecule derived from an originally tricistronic pre-rRNA transcript that contained the Small Subunit (SSU) rRNA, the 5.8S rRNA, and the Large Subunit (LSU) rRNA in that order from 5' to 3' along the primary transcript. |
| isotype switching | The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus. |
| nuclear polyadenylation-dependent rRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a ribosomal RNA (rRNA) molecule, including RNA fragments released as part of processing the primary transcript into multiple mature rRNA species, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target rRNA. |
| nuclear polyadenylation-dependent tRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of an aberrant or incorrectly modified transfer RNA (tRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target tRNA. |
| nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' | The chemical reactions and pathways resulting in the breakdown of the mRNA transcript body that occurs when the 3' end is not protected by a 3'-poly(A) tail; degradation proceeds in the 3' to 5' direction. |
| polyadenylation-dependent snoRNA 3'-end processing | Any process involved in forming the mature 3' end of a snoRNA molecule linked to prior polyadenylation of the 3'-end of the precursor snoRNA. |
| positive regulation of isotype switching | Any process that activates or increases the frequency, rate or extent of isotype switching. |
| U4 snRNA 3'-end processing | Any process involved in forming the mature 3' end of a U4 snRNA molecule. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAEAAGVPAE | SLAGCRARAA | RTVLDQVVLP | GEELLLPDQE | DGDGPGGAGE | RPLRLNAAAR |
| 70 | 80 | 90 | 100 | 110 | 120 |
| SRGRVVCGPG | LRRCGDRLLV | TKCGRLRHKE | PGSGSGGGVY | WVDSQQKRYV | PVKGDHVIGI |
| 130 | 140 | 150 | 160 | 170 | 180 |
| VTAKSGDIFK | VDVGGSEPAS | LSYLAFEGAT | KRNRPNVQVG | DLIYGQFVVA | NKDMEPEMVC |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IDSCGRANGM | GVIGQDGLLF | KVTLGLIRKL | LAPDCEILQE | VGKLYPLEIV | FGMNGRIWVK |
| 250 | 260 | 270 | |||
| AKTIQQTLIL | ANILEACEHM | TADQRKQIFS | RLAES |